Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TrEAT_TD2: Rifaximin vs Azithromycin for Traveler's Diarrhea
NCT05677282Phase 4Recruiting
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Start
- Oct 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of rifaximin in traveler's diarrhea (TD), sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine. Started Oct 2022; status: recruiting.
02
Drugs
rifaximin
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT05677282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05677282.